MedPage Today -- The investigational anticoagulant rivaroxaban (Xarelto), given after knee surgery, showed significantly better efficacy and equivalent safety compared with enoxaparin (Lovenox), researchers said.
MedPage Today -- The investigational anticoagulant rivaroxaban (Xarelto), given after knee surgery, showed significantly better efficacy and equivalent safety compared with enoxaparin (Lovenox), researchers said.